Isobolographic analysis of pharmacodynamic interactions between antifungal agents and ciprofloxacin against Candida albicans and Aspergillus fumigatus
- PMID: 18299413
- PMCID: PMC2415767
- DOI: 10.1128/AAC.00735-07
Isobolographic analysis of pharmacodynamic interactions between antifungal agents and ciprofloxacin against Candida albicans and Aspergillus fumigatus
Abstract
Patients suffering from invasive mycoses often receive concomitant antifungal therapy and antibacterial agents. Assessment of pharmacodynamic interactions between antifungal and antibacterial agents is complicated by the absence of a common antifungal end point for both agents. Ciprofloxacin has no intrinsic antifungal activity but may interact with antifungal agents, since it inhibits DNA gyrase (topoisomerase II), which is abundant in fungi. We therefore employed isobolographic analysis adapted to incorporate a nonactive agent in order to analyze the potential in vitro interaction between the fluoroquinolone ciprofloxacin and several representative antifungal agents against Candida albicans and Aspergillus fumigatus strains by using a microdilution checkerboard technique. In agreement with earlier in vitro studies, conventional fractional inhibitory concentration index analysis was unable to detect interactions between ciprofloxacin and antifungal agents. However, isobolographic analysis revealed significant pharmacodynamic interactions between antifungal agents and ciprofloxacin against C. albicans and A. fumigatus strains. Amphotericin B demonstrated concentration-dependent interactions for both species, with synergy (interaction indices, 0.14 to 0.81) observed at ciprofloxacin concentrations of <10.64 microg/ml. Synergy (interaction indices, 0.10 to 0.86) was also found for voriconazole and caspofungin against A. fumigatus. Isobolographic analysis may help to elucidate the pharmacodynamic interactions between antifungal and non-antifungal agents and to develop better management strategies against invasive candidiasis and aspergillosis.
Figures


Similar articles
-
Synergistic interaction of the triple combination of amphotericin B, ciprofloxacin, and polymorphonuclear neutrophils against Aspergillus fumigatus.Antimicrob Agents Chemother. 2011 Dec;55(12):5923-9. doi: 10.1128/AAC.00548-11. Epub 2011 Sep 12. Antimicrob Agents Chemother. 2011. PMID: 21911564 Free PMC article.
-
Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatus.J Antimicrob Chemother. 2009 Feb;63(2):343-8. doi: 10.1093/jac/dkn473. Epub 2008 Dec 24. J Antimicrob Chemother. 2009. PMID: 19109335 Free PMC article.
-
Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model.Antimicrob Agents Chemother. 2007 Jun;51(6):2053-64. doi: 10.1128/AAC.00873-06. Epub 2007 Mar 26. Antimicrob Agents Chemother. 2007. PMID: 17387150 Free PMC article.
-
Caspofungin: first approved agent in a new class of antifungals.Expert Opin Pharmacother. 2003 May;4(5):807-23. doi: 10.1517/14656566.4.5.807. Expert Opin Pharmacother. 2003. PMID: 12740003 Review.
-
Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.Dan Med J. 2016 Oct;63(10):B5288. Dan Med J. 2016. PMID: 27697142 Review.
Cited by
-
A review of cosmetic contact lens infections.Eye (Lond). 2019 Jan;33(1):78-86. doi: 10.1038/s41433-018-0257-2. Epub 2018 Nov 1. Eye (Lond). 2019. PMID: 30385879 Free PMC article. Review.
-
Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus species.Virulence. 2011 Jul-Aug;2(4):280-95. doi: 10.4161/viru.2.4.16764. Epub 2011 Jul 1. Virulence. 2011. PMID: 21701255 Free PMC article. Review.
-
Antiviral, antifungal, and antiparasitic activities of fluoroquinolones optimized for treatment of bacterial infections: a puzzling paradox or a logical consequence of their mode of action?Eur J Clin Microbiol Infect Dis. 2015 Apr;34(4):661-8. doi: 10.1007/s10096-014-2296-3. Epub 2014 Dec 17. Eur J Clin Microbiol Infect Dis. 2015. PMID: 25515946 Free PMC article. Review.
-
Synergistic interaction of the triple combination of amphotericin B, ciprofloxacin, and polymorphonuclear neutrophils against Aspergillus fumigatus.Antimicrob Agents Chemother. 2011 Dec;55(12):5923-9. doi: 10.1128/AAC.00548-11. Epub 2011 Sep 12. Antimicrob Agents Chemother. 2011. PMID: 21911564 Free PMC article.
-
Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatus.J Antimicrob Chemother. 2009 Feb;63(2):343-8. doi: 10.1093/jac/dkn473. Epub 2008 Dec 24. J Antimicrob Chemother. 2009. PMID: 19109335 Free PMC article.
References
-
- American Society for Microbiology. 2007. Instructions to authors. Antimicrob. Agents Chemother. 51:1-22.
-
- Antoniadou, A., and H. Giamarellou. 2007. Fever of unknown origin in febrile leukopenia. Infect. Dis. Clin. N. Am. 21:1055-1090. - PubMed
-
- Berenbaum, M. C. 1989. What is synergy? Pharmacol. Rev. 41:93-141. - PubMed
-
- Borowicz, K. K., M. Swiader, J. Luszczki, and S. J. Czuczwar. 2002. Effect of gabapentin on the anticonvulsant activity of antiepileptic drugs against electroconvulsions in mice: an isobolographic analysis. Epilepsia 43:956-963. - PubMed
-
- Faessel, H. M., L. M. Levasseur, H. K. Slocum, and W. R. Greco. 1999. Parabolic growth patterns in 96-well plate cell growth experiments. In Vitro Cell. Dev. Biol. Anim. 35:270-278. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical